(Q45411920)

14 December 2017

title

Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector (English)

1 reference

14 December 2017

0 references

1 reference

2

1 reference

14 December 2017

3

1 reference

14 December 2017

Daisuke Watanabe

1

0 references

author name string

Lydia Mathews

4

1 reference

14 December 2017

William T Lucas

5

1 reference

14 December 2017

Cynthia G Murphy

6

1 reference

14 December 2017

Barbara K Felber

7

1 reference

14 December 2017

George N Pavlakis

8

1 reference

14 December 2017

Neal A Deluca

9

1 reference

14 December 2017

David M Knipe

10

1 reference

14 December 2017

language of work or name

English

0 references

publication date

22 September 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

357

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

186-198

1 reference

Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Humoral response to herpes simplex virus is complement-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Molecular genetics of herpes simplex virus: Demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

The Role of Toll‐Like Receptors in Herpes Simplex Infection in Neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Replacement of posttranscriptional regulation in SIVmac239 generated a Rev-independent infectious virus able to propagate in rhesus peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

A new method for the isolation of herpes simplex virus type 2 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Relationship between HLA I surface expression and different cytopathic effects produced after herpes simplex virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.08.015

1 reference

14 December 2017

1 reference